Antimicrobial Use and Control of Clostridium difficile transmission and infection
Antimicrobial Use and Control of Clostridium difficile transmission and infection
批准号:
8280096
负责人:
MICHAEL A. RUBIN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-01-01 至 2014-12-31
关键词:
AddressAffectAntibioticsClostridium difficileComplexComputer SimulationContainmentCost-Benefit AnalysisCosts and BenefitsDataDatabasesDiarrheaDisease OutbreaksEffectivenessEnvironmentEpidemicEpidemiologic MethodsEpidemiologic StudiesEpidemiologyEvaluationExposure toFutureHandHealth Care CostsHealthcareHealthcare SystemsHospitalsHygieneIncidenceIndividualInfectionInfection ControlInterventionKnowledgeLength of StayMediatingMethodsMindModelingNosocomial InfectionsOutcomePatient CarePatientsPatternPersonsPoliciesPopulationProcessRelative (related person)ResearchResearch PersonnelRiskRisk FactorsSeriesServicesSystemTechniquesTimeTranslational ResearchVariantVeteransWorkadvanced simulationantimicrobialantimicrobial drugbasecostdesignfactor Chigh riskimprovedinnovationmodels and simulationmortalitynovelpathogenresearch studyresponsesimulationtooltransmission process
中文摘要
描述(由申请人提供):
艰难梭菌中抗生素处方的传播和控制对退伍军人保健的预期影响我们的工作将为艰难梭菌不同控制政策的有效性和成本效益提供有价值的信息。通过研究设施水平的抗生素处方与艰难梭菌感染率(CDI)之间的关系,以及CDI的各种控制策略的影响和成本,我们可能会更好地了解艰难梭菌的传播动态,这将有助于实施旨在控制CDI的VA范围内的倡议,如抗生素管理。该项目的发现有可能影响整个退伍军人管理局医疗系统的感染控制实践。艰难梭菌是引起卫生保健相关腹泻的主要感染原因,也是最常见的卫生保健获得性感染类型之一,导致住院时间延长、死亡率增加和医疗费用增加。接触抗生素是CDI最重要的危险因素,可能是通过破坏正常的粪便菌群。虽然已经提出了一些方法来控制CDI的暴发,如改善手部卫生和抗生素管理,但关于这些干预措施如何改变艰难梭菌的传播和获得并有助于控制它,人们了解很少。项目目标艰难梭菌的传播依赖于无数因素和过程的相互作用。通过了解这些相互作用和不同控制策略对艰难梭菌传播动态的相对影响,有助于设计控制医院内CDI的政策。考虑到这一点,我们的目标是(A)对抗生素使用模式和CDI率之间的关联进行设施级别的分析
(B)将这些模式和关联纳入我们对艰难梭菌院内传播的基于试剂的模拟;(C)利用模拟来评估和比较退伍军人医院艰难梭菌控制的替代和新政策,包括抗生素管理;以及(D)探索这些干预策略在不同条件下的影响,包括引入流行的艰难梭菌菌株。方法我们将改进和增强基于高保真试剂的医院艰难梭菌医院传播的计算机模拟,作为先前项目的一部分。我们对抗生素处方和CDI比率的分析将基于我们从患者护理服务获得的全国范围内的VA患者数据的大型数据库。结合来自150多家退伍军人医院的个人和医院层面的数据,可以建立模型,分别估计抗菌剂对CDI风险的直接影响,以及通过人与人之间的传播调节的间接影响。分层混合效应模型将被用来描述CDI发生率与患者和医院水平因素之间的关联。这些分析的结果将被纳入TH模拟,然后将被用于通过一系列模拟实验评估影响艰难梭菌传播的各种策略和因素。将使用传统的定量流行病学方法来分析模拟结果,重点是艰难梭菌的发病率和传播率作为结果。还将根据各种替代政策预测艰难梭菌的发病率和成本,从而进行动态成本效益分析。
政权。
英文摘要
DESCRIPTION (provided by applicant):
Antibiotic prescribing in Clostridium difficile transmission and control Anticipated Impacts on Veteran's Health Care Our work will provide valuable information on the effectiveness and cost-benefit of different control policies for Clostridium difficile. By examining the associations between facility-level antibiotic prescribing and C. difficile infection (CDI) rates, and the impac and costs of various control strategies for CDI, we may gain a better understanding of the dynamics of C. difficile transmission in ways that will contribute to the implementation of VA-wide initiatives aimed at controlling CDI, such as antibiotic stewardship. The findings from this project have the potential to impact infection control practice throughout the VA healthcare system. Project Background C. difficile is the predominant infectious cause of healthcare-associated diarrhea and one of the most common types of healthcare-acquired infection, resulting in prolonged hospital stays, higher mortality, and increased healthcare costs. Exposure to antibiotics is the most important risk factor for CDI, presumably through the disruption of the normal fecal flora. Although a number of approaches have been proposed to contain outbreaks of CDI, such as improved hand hygiene and antibiotic stewardship, little is understood about how these interventions alter the dynamics of C. difficile transmission and acquisition and contribute to its control. Project Objectives C. difficile transmission is dependent on the interactions of innumerable factors and processes. The design of policies to control nosocomial CDI is aided by an understanding of these interactions and the relative impact of different control strategies on C. difficile transmission dynamics. With this in mind, our objectives are to (a) perform a facility-level analysis of associations between antibiotic use patterns and CDI rates
at VA hospitals nationwide; (b) incorporate these patterns and associations into our agent-based simulation of nosocomial C. difficile transmission; (c) use the simulation to evaluate and compare alternative and novel policies for C. difficile control in VA hospitals, including antibiotc stewardship; and (d) explore the impact of these intervention strategies under varying conditions, including the introduction of an epidemic C. difficile strain. Methods We will refine and enhance a high-fidelity agent-based computer simulation of nosocomial C. difficile transmission created as part of a previous project. Our analyses of antibiotic prescribing and CDI rates will be based on a large, nationwide database of VA patient data that we have obtained from Patient Care Services. The combination of individual- and hospital-level data from more than 150 VA hospitals makes it feasible to fit models that separately estimate direct effects of antimicrobial agents on CDI risk from their indirect effects mediated through person-to-person spread. Hierarchical mixed effects models will be used to characterize the association of CDI rates to patient and hospital level factors. Results of these analyses will be incorporated into th simulation, which will then be used to assess the various strategies and factors that impact C. difficile transmission through a series of simulation experiments. Traditional quantitative epidemiologic methods will be used to analyze simulation results, with a focus on C. difficile incidence and transmission rates as outcomes. Dynamic cost-benefit analyses will also be performed by projecting C. difficile incidence rates and costs under the various alternative policy
regimes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intermountain Program on Antibiotic Resistance and microbial Threats (IMPART)
-
批准号:10646169
-
项目类别:
-
资助金额:$73.72万
-
财政年份:2021
-
负责人:MICHAEL A. RUBIN
-
依托单位:
Intermountain Program on Antibiotic Resistance and microbial Threats (IMPART)
-
批准号:10466713
-
项目类别:
-
资助金额:$26.08万
-
财政年份:2021
-
负责人:MICHAEL A. RUBIN
-
依托单位:
Antimicrobial Use and Control of Clostridium difficile transmission and infection
-
批准号:8510478
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:MICHAEL A. RUBIN
-
依托单位:
Improving MRSA control through simulation and surveillance
-
批准号:8195234
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:MICHAEL A. RUBIN
-
依托单位:
Improving MRSA control through simulation and surveillance
-
批准号:7893673
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:MICHAEL A. RUBIN
-
依托单位:
Improving MRSA control through simulation and surveillance
-
批准号:7749870
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:MICHAEL A. RUBIN
-
依托单位:
Undergraduate Research in Bioinformatics at UPR-Cayey Campus
-
批准号:6980147
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2004
-
负责人:MICHAEL A. RUBIN
-
依托单位:
UNDERGRADUATE RESEARCH IN BIOINFORMATICS AT UPR-CAYEY CAMPUS
-
批准号:7181679
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2004
-
负责人:MICHAEL A. RUBIN
-
依托单位:
Antibiotic use and bacteriuria in the rural nursing home
-
批准号:6799700
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2003
-
负责人:MICHAEL A. RUBIN
-
依托单位:
Antibiotic use and bacteriuria in the rural nursing home
-
批准号:7279320
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2003
-
负责人:MICHAEL A. RUBIN
-
依托单位:
Antibiotic use and bacteriuria in the rural nursing home
-
批准号:6909147
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2003
-
负责人:MICHAEL A. RUBIN
-
依托单位:
Antibiotic use and bacteriuria in the rural nursing home
-
批准号:7092125
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2003
-
负责人:MICHAEL A. RUBIN
-
依托单位:
Antibiotic use and bacteriuria in the rural nursing home
-
批准号:6706739
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2003
-
负责人:MICHAEL A. RUBIN
-
依托单位:
海外基金